Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Other Accumulated Expenses (2024 - 2025)

Carlsmed (CARL) has disclosed Other Accumulated Expenses for 2 consecutive years, with $325000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Accumulated Expenses changed N/A year-over-year to $325000.0, compared with a TTM value of $325000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $536000.0, changed N/A over the prior year.
  • Other Accumulated Expenses was $325000.0 for Q3 2025 at Carlsmed, down from $536000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $536000.0 in Q4 2024 and bottomed at $325000.0 in Q3 2025.